ANGO Angiodynamics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ANGO

Price (delayed)

$15.32

Market cap

$633.21M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.88

Enterprise value

$579.35M

?
Relative Growth: Rel. Growth: 24
Relative Strength: Rel. Strength: 87
Relative Valuation: Rel. Valuation: 21
Relative Profitability: Rel. Profitability: 26

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for ...

Highlights
ANGO's gross profit is up by 11% year-on-year and by 2.7% since the previous quarter
The revenue has increased by 9% year-on-year and by 2.1% since the previous quarter
ANGO's net income is down by 17% since the previous quarter and by 8% year-on-year
Angiodynamics's EPS has decreased by 17% from the previous quarter and by 6% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.angiodynamics.com
Peers: LMAT MMSI TFX ICUI

Key stats

What are the main financial stats of ANGO

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
3.58%
1 week
12.15%
1 month
17.04%
1 year
78.97%
YTD
19.31%
QTD
17.76%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$320.17M
Gross profit
$174.89M
Operating income
-$36M
Net income
-$36.74M
Gross margin
54.6%
Net margin
-11.5%
ANGO's operating income is down by 18% since the previous quarter and by 3.6% year-on-year
ANGO's net income is down by 17% since the previous quarter and by 8% year-on-year
The company's operating margin fell by 15% QoQ but it rose by 6% YoY
The company's net margin fell by 15% QoQ

Price vs fundamentals

How does ANGO's price correlate with its fundamentals

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
3.71
P/S
1.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.81
Angiodynamics's EPS has decreased by 17% from the previous quarter and by 6% YoY
The P/B is 99% more than the 5-year quarterly average of 1.8 and 33% more than the last 4 quarters average of 2.7
Angiodynamics's equity has decreased by 7% YoY
The P/S is 28% more than the last 4 quarters average of 1.5 and 13% more than the 5-year quarterly average of 1.7
The revenue has increased by 9% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Angiodynamics business performance
The ROE is down by 19% since the previous quarter and by 16% year-on-year
ANGO's ROIC is down by 18% QoQ
ANGO's ROA is down by 18% since the previous quarter and by 17% year-on-year
Angiodynamics's ROS has decreased by 13% from the previous quarter but it has increased by 7% YoY

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
Angiodynamics's total assets is 177% higher than its total liabilities
The company's total liabilities rose by 10% QoQ
The quick ratio has increased by 9% QoQ and by 5% YoY
The company's debt is 100% lower than its equity
Angiodynamics's equity has decreased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.